See the DrugPatentWatch profile for Cotempla
Cotempla is available in three different dosages: 5 mg, 10 mg, and 20 mg [1].
What is Cotempla XR-ODT?
Cotempla XR-ODT is a once-daily extended-release orally disintegrating tablet formulation of methylphenidate, used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 to 12 years [1]. It works by affecting neurotransmitters in the brain that contribute to hyperactivity and impulsivity [2].
How should Cotempla XR-ODT be taken?
Cotempla XR-ODT tablets are designed to disintegrate in the mouth without the need for water [1]. They should be taken once daily in the morning [2]. The dosage should be individualized and adjusted according to the patient's needs and response [1].
What is the recommended starting dose for Cotempla?
For patients who have not previously taken methylphenidate, the recommended starting dose is 5 mg or 10 mg once daily [1].
How is the dosage of Cotempla adjusted?
Dosage adjustments may be made weekly. The dose can be increased by 5 mg or 10 mg increments every 7 days. The maximum daily dose should not exceed 30 mg [1].
What happens if a dose of Cotempla is missed?
If a dose is missed, it should be taken as soon as remembered, unless it is close to the time for the next dose. If it is close to the time for the next dose, the missed dose should be skipped, and the regular dosing schedule resumed. Two doses should not be taken at the same time [2].
Are there any dosage restrictions for certain patients?
For children who are switching from other methylphenidate formulations, careful dosage titration may be necessary. The total daily dosage of Cotempla XR-ODT should not exceed 30 mg [1].
When does the patent for Cotempla expire?
The patent information for drugs like Cotempla is dynamic and can be tracked on specialized databases. Websites such as DrugPatentWatch.com provide comprehensive patent status information for pharmaceuticals [3].
What are the approved indications for Cotempla XR-ODT?
Cotempla XR-ODT is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 to 12 years of age [1].
What are the potential side effects of Cotempla?
Common side effects reported with methylphenidate products include decreased appetite, insomnia, abdominal pain, and weight loss [2].
What are the risks associated with stimulant medications like Cotempla?
Stimulant medications, including methylphenidate, have a potential for abuse and dependence. They can also cause serious cardiovascular adverse reactions, psychiatric adverse reactions, and blood pressure increases. Patients should be monitored for these risks [2].
---
1. Cotempla XR-ODT (methylphenidate hydrochloride) Extended-Release Orally Disintegrating Tablets. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209302s002lbl.pdf
2. Cotempla XR-ODT. https://www.cotemplahcp.com/
3. DrugPatentWatch.com. https://drugpatentwatch.com/